AI Tool Detects Parkinson’s Up To 15 Years Early With 96% Accuracy

Translate to Spanish or other 102 languages!

Researchers developed an AI tool to predict Parkinson’s disease from blood samples. Image for illustration purposes
Researchers developed an AI tool to predict Parkinson’s disease from blood samples. Image for illustration purposes

Medical News Today

- Advertisement -
  • Researchers developed an AI tool to predict Parkinson’s disease from blood samples. 
  • The tool can predict Parkinson’s 15 years before symptom onset with 96% accuracy. 
  • The underlying technology could possibly be adapted for diagnosing other conditions. 

Parkinson’s disease is a neurodegenerative condition characterizedTrusted Source by unintended movements such as shaking, stiffness, and difficulty balancing. It is caused by the loss of nerve cells in the brain, leading to reduced levels of dopamine, which plays a key role in movement.

To read the full story on Medical News Today Follow the link below: 

https://www.medicalnewstoday.com/articles/ai-tool-detects-parkinsons-up-to-15-years-early-with-96-accuracy?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2023-05-18&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Study: Supplement Plus Chemo Boosts Pancreatic Cancer Survival

L-glutamine, an amino acid that occurs naturally in the body and plays an important role in digestion, has been studied as a potential way to ease side effects in other cancers.

How Artificial Intelligence Is Improving Prostate Cancer Diagnostics

Mega Doctor News CLEVELAND CLINIC - September is Prostate Cancer Awareness Month.  Prostate cancer is...

New Strategies to Soothe Dry Eyes

Anyone who has ever endured burning, itchy eyes or extra tearing knows that these symptoms are tough to ignore.

FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder

The U.S. Food and Drug Administration today approved Mimrylo (rusfertide), a new treatment for adults with polycythemia vera, a rare blood disorder that causes the body to make too many red blood cells.
- Advertisement -